Concepedia

Kelly M. Lohr

KM

Statistics

Publications

16

Citations

970

H-Index

14

Active since

1992

Affiliations

Emory University(Current)

University of Toronto

Harvard University

Brigham and Women's Hospital

National Institutes of Health

Kelly M. Lohr is an author at Emory University specializing in life sciences, neuroscience, and molecular neuroscience.

ORCID

Publications per year

1992–2021

16

Publications

16

Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo

Kelly M. Lohr, Alison I. Bernstein, Kristen A. Stout et al. · Proceedings of the National Academy of Sciences · 2014 · 239 citations · Full text

, , +17

Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease

Amy R. Dunn, Kristen A. Stout, Minagi Ozawa et al. · Proceedings of the National Academy of Sciences · 2017 · 153 citations · Full text

, , +17

α-synuclein impairs autophagosome maturation through abnormal actin stabilization

Souvarish Sarkar, Abby L. Olsen, Katja Sygnecka et al. · PLoS Genetics · 2021 · 93 citations · Full text

, , +17

Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits

Svenja V. Trossbach, Verian Bader, Laura Hecher et al. · Molecular Psychiatry · 2016 · 91 citations · Full text

, , +15

Increased Vesicular Monoamine Transporter 2 (VMAT2;<i>Slc18a2</i>) Protects against Methamphetamine Toxicity

Kelly M. Lohr, Kristen A. Stout, Amy R. Dunn et al. · ACS Chemical Neuroscience · 2015 · 70 citations

, , +17

1–5 of 16